News Azure Health Technology Australian S.E.

Equities

AZT

End-of-day quote Australian S.E. Other stock markets			5-day change	1st Jan Change
- ^AUD	-.--%		-.--%	-.--%

08/02	VGI Health Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
2023	VGI Health Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

VGI Health Technology Limited New Partnership	15/02	AW
VGI Health Technology Limited (NSX:VTL) New Partnership	15/02	AQ
VGI Health Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2023	08/02	CI
VGI Health Technology Limited HREC Approval for Phase II Clinical Study	11/01	AW
VGI Health Technology Limited Reports Earnings Results for the Full Year Ended June 30, 2023	07/23/07	CI
VGI Health Technology Limited commences divestment of Invictus BioPharma Pty Ltd	29/23/29	AW
VGI Health Technology Limited (NSX:VTL) commences divestment of Invictus BioPharma Pty Ltd	29/23/29	AQ
Certain Ordinary Shares of VGI Health Technology Limited are subject to a Lock-Up Agreement Ending on 28-MAY-2023.	28/23/28	CI
VGI Health Technology Limited Reports Earnings Results for the Half Year Ended December 31, 2022	16/23/16	CI
VGI Health Technology Limited Quarterly Update	31/23/31	AW
VGI Health Technology Limited (NSX:VTL) Quarterly Update	31/23/31	AQ
VGI Health Technology Limited Update on Sale of Invictus BioPharma	22/22/22	AW
VGI Health Technology Limited (NSX:VTL) Update on Sale of Invictus BioPharma	22/22/22	AQ
VGI Health Technology Limited R & D Facility Agreement with Fundsquire Pty Ltd	13/22/13	AW
VGI Health Technology Limited (NSX:VTL) R & D Facility Agreement with Fundsquire Pty Ltd	13/22/13	AQ
VGI Health Technology Limited NAFLD/NASH Phase II Clinical Study	05/22/05	AW
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH Phase II Clinical Study	05/22/05	AQ
VGI Health Technology Limited Receives Ethics Approval for US Clinical Study	26/22/26	AW
VGI Health Technology Limited NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient	14/22/14	AW
VGI Health Technology Limited (NSX:VTL) NAFLD/NASH PhaseII Clinical Study Recruits 1st Patient	14/22/14	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Azure Health Technology Australian S.E.

Equities

AZT

Summary

Filters